ADVB

Advanced Biomed Inc

Apr 02 • 04:00PM ET

4.55

+0.09 2.02 %

Healthcare • Diagnostics & Research • Taiwan • NASD

Index	-	P/E	34.37	EPS (ttm)	0.13	Insider Own	72.86%	Shs Outstand	1.08M	Perf Week	8.59%
Market Cap	6.21M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.37M	Perf Month	-0.87%
Enterprise Value	6.15M	PEG	-	EPS next Q	-	Inst Own	0.16%	Short Float	3.47%	Perf Quarter	-22.04%
Income	0.14M	P/S	-	EPS this Y	-	Inst Trans	-72.88%	Short Ratio	0.08	Perf Half Y	-49.22%
Sales	0.00M	P/B	16.31	EPS next Y	-	ROA	61.27%	Short Interest	0.01M	Perf YTD	-22.04%
Book/sh	0.28	P/C	77.62	EPS next 5Y	-	ROE	92.23%	52W High	80.00 -94.31%	Perf Year	-93.80%
Cash/sh	0.06	P/FCF	-	EPS past 3/5Y	10.67% -12.01%	ROIC	46.89%	52W Low	3.61 26.04%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.99% 8.69%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	242.37%	Oper. Margin	-	ATR (14)	0.46	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.56	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.53	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	8.56	EPS Q/Q	888.42%	SMA20	-1.20%	Beta	-2.14	Target Price	-
Payout	-	Debt/Eq	0.07	Sales Q/Q	-	SMA50	-5.10%	Rel Volume	0.02	Prev Close	4.46
Employees	31	LT Debt/Eq	0.00	Earnings	-	SMA200	-44.97%	Avg Volume	167.24K	Price	4.55
IPO	Mar 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	2,937	Change	2.02%

Feb-18-26 07:00AM	Advanced Biomed Inc. Announces 1 for 20 Share Consolidation (GlobeNewswire) -10.69%
Feb-13-26 08:00AM	Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire)
Dec-31-25 10:25AM	Advanced Biomed sells Hong Kong subsidiary for $23,000 (TipRanks) -13.82%
Dec-30-25 10:17AM	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary (GlobeNewswire)
Sep-19-25 08:30AM	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire) -17.18%
12:29PM	Loading…
Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADVB

Advanced Biomed Inc

Upgrade your Finviz experience